ATE210466T1 - Methoden zur behandlung von atemwegserkrankungen - Google Patents

Methoden zur behandlung von atemwegserkrankungen

Info

Publication number
ATE210466T1
ATE210466T1 AT96910597T AT96910597T ATE210466T1 AT E210466 T1 ATE210466 T1 AT E210466T1 AT 96910597 T AT96910597 T AT 96910597T AT 96910597 T AT96910597 T AT 96910597T AT E210466 T1 ATE210466 T1 AT E210466T1
Authority
AT
Austria
Prior art keywords
methods
treating respiratory
respiratory diseases
sinusitis
emphysema
Prior art date
Application number
AT96910597T
Other languages
English (en)
Inventor
John Mcmichael
Original Assignee
Milkhaus Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milkhaus Lab Inc filed Critical Milkhaus Lab Inc
Application granted granted Critical
Publication of ATE210466T1 publication Critical patent/ATE210466T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96910597T 1995-04-13 1996-03-20 Methoden zur behandlung von atemwegserkrankungen ATE210466T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42123295A 1995-04-13 1995-04-13
PCT/US1996/004197 WO1996032138A1 (en) 1995-04-13 1996-03-20 Methods for treating respiratory disease

Publications (1)

Publication Number Publication Date
ATE210466T1 true ATE210466T1 (de) 2001-12-15

Family

ID=23669712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96910597T ATE210466T1 (de) 1995-04-13 1996-03-20 Methoden zur behandlung von atemwegserkrankungen

Country Status (8)

Country Link
US (2) US5726160A (de)
EP (1) EP0766570B1 (de)
JP (1) JP2961709B2 (de)
AT (1) ATE210466T1 (de)
AU (1) AU716486B2 (de)
CA (1) CA2192674C (de)
DE (1) DE69617856T2 (de)
WO (1) WO1996032138A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US7935675B1 (en) 1994-07-15 2011-05-03 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6096721A (en) * 1995-04-13 2000-08-01 Milkhaus Laboratory, Inc. Method for treating mucositis by sublingual administration of DNA
US20020115632A1 (en) * 1995-04-13 2002-08-22 Milkhaus Laboratory, Inc. Treatment of symptoms of asthma and allergies
US20030032614A1 (en) * 1995-04-13 2003-02-13 Mcmichael John Method of treating respiratory distress using synthetic polynucleic acids
US5948768A (en) * 1995-04-13 1999-09-07 Milkhaus Laboratory Treatment of otitis media by sublingual administration of DNA
ATE210466T1 (de) * 1995-04-13 2001-12-15 Milkhaus Lab Inc Methoden zur behandlung von atemwegserkrankungen
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
US5877198A (en) * 1996-10-17 1999-03-02 Milkhaus Laboratory, Inc. Treatment of urinary incontinence
US6998121B2 (en) 2003-01-23 2006-02-14 Milkhaus Laboratory, Inc. Method of treatment of connective tissue disorders by administration of streptolysin O
AU760795B2 (en) * 1998-05-14 2003-05-22 Coley Pharmaceutical Gmbh Methods for regulating hematopoiesis using CpG-oligonucleotides
US7585847B2 (en) 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
US7956043B2 (en) * 2002-12-11 2011-06-07 Coley Pharmaceutical Group, Inc. 5′ CpG nucleic acids and methods of use
US20100144602A1 (en) * 2003-01-23 2010-06-10 Milkhaus Laboratory, Inc. Methods of Inhibiting Metastatic Cancer by Administration of Streptolysin O
US7629312B2 (en) 2003-01-23 2009-12-08 Milkhaus Laboratory, Inc. Method of treatment of tendonitis by administration of streptolysin O
TWI235440B (en) * 2004-03-31 2005-07-01 Advanced Semiconductor Eng Method for making leadless semiconductor package
EP1874325A2 (de) * 2005-04-08 2008-01-09 Coley Pharmaceutical Group, Inc. Verfahren zur behandlung von durch infektionserkrankungen verschlimmertes asthma
US20080182789A1 (en) * 2007-01-30 2008-07-31 Milkhaus Laboratory, Inc. Method of treating pulmonary fibrosis
US8980826B2 (en) 2012-02-27 2015-03-17 Beech Tree Labs, Inc. Method of treating chronic obstructive pulmonary disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
US5240846A (en) * 1989-08-22 1993-08-31 The Regents Of The University Of Michigan Gene therapy vector for cystic fibrosis
GB9027968D0 (en) * 1990-12-22 1991-02-13 Fisons Plc Method of treatment
EP0517573A1 (de) * 1991-06-05 1992-12-09 Synthelabo Pharmazeutische Zusammensetzungen zur Behandlung von Atemwegserkrankungen
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
US6001644A (en) * 1991-12-17 1999-12-14 The Regents Of The University Of California Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
AU680508B2 (en) * 1993-04-06 1997-07-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Gibbon ape leukemia virus-based retroviral vectors
DE4410188A1 (de) * 1994-03-24 1995-09-28 Boehringer Mannheim Gmbh Gentherapeutisches Verfahren unter Verwendung von antibiotikaresistenzgenfreien DNA-Vektoren
ATE210466T1 (de) * 1995-04-13 2001-12-15 Milkhaus Lab Inc Methoden zur behandlung von atemwegserkrankungen
US5635160A (en) * 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5628984A (en) * 1995-07-31 1997-05-13 University Of North Carolina At Chapel Hill Method of detecting lung disease

Also Published As

Publication number Publication date
JP2961709B2 (ja) 1999-10-12
US5726160A (en) 1998-03-10
EP0766570A4 (de) 1998-11-11
EP0766570B1 (de) 2001-12-12
DE69617856D1 (de) 2002-01-24
US5955442A (en) 1999-09-21
AU5375196A (en) 1996-10-30
CA2192674C (en) 2001-02-13
JPH10500430A (ja) 1998-01-13
AU716486B2 (en) 2000-02-24
DE69617856T2 (de) 2002-06-27
WO1996032138A1 (en) 1996-10-17
EP0766570A1 (de) 1997-04-09

Similar Documents

Publication Publication Date Title
DE69617856D1 (de) Methoden zur behandlung von atemwegserkrankungen
CA2223776A1 (en) Method of treatment for lung diseases using antisense oligonucleotides
FR2722506B1 (fr) Composition contenant des acides nucleiques, preparation et utilisations
ATE230439T1 (de) Gezielte gentherapie
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
DE60031456D1 (de) Rekombinante alpha-l-iduronisase, deren herstellungs- und aufreinigungsverfahren, und behandlung von durch diese hervorgerufene mangelerkrankungen
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE69625906D1 (de) Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
DE69716255D1 (de) Verfahren zur behandlung von mittelohrentzündung mittels uridintriphosphaten und verwandten mitteln
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
JP2005112863A (ja) 網膜の色素沈着された上皮由来の神経栄養性因子
DE60126495D1 (de) Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
DE69725879D1 (de) VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN
ES2187648T3 (es) Metodo para la administracion de farmacos para terapia genica.
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
CA2323213A1 (en) Treatment of respiratory disease and otitis media
NO991292L (no) Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
DE69627298D1 (de) Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
EP1143996A4 (de) Methode zur behandlung von chronischen herzerkrankungen
RU95100951A (ru) Способ лечения мужского бесплодия
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
SE9300509D0 (sv) Peg treatment

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties